Oral Glucose Tolerance Test
Oral Glucose Tolerance Test is an intervention with 82 clinical trials. Currently 9 active trials ongoing. Historical success rate of 90.6%.
Success Metrics
Based on 48 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
84.2%
48 of 57 finished
15.8%
9 ended early
9
trials recruiting
82
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
The HIV, Adipose Tissue Immunology, and Metabolism Study
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test
Pharmacogenetics of Response to Sitagliptin (PRS)
Clinical Trials (82)
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
The HIV, Adipose Tissue Immunology, and Metabolism Study
Peri-operative Dynamics of the Growth Hormone Axis in Subjects With Acromegaly
Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Oral Glucose Tolerance Test
Pharmacogenetics of Response to Sitagliptin (PRS)
Impact of Thyroid Hormones on Human Glucose and Energy Metabolism
Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
Study of Metabolic Modifications in Children With Noonan Syndrome
Sarcopenia in Gestational Diabetes
Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease
Glucose Metabolism and Live Birth Outcomes in PCOS
Comparing the Effects of Exercise on the Structure and Function of Fat Tissue
Oral Propionate to Treat and Prevent Diabetes
Glucose-homeostasis After Endoscopic Sleeve Gastroplasty
Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver Disease
Transcriptional and Epigenetic Program of PCOS Women
Alternate Measures of Glucose During OGTT Testing for CFRD
Artificial Intelligence to Improve Cardiometabolic Risk Evaluation Using CT Scans
EnVision CF Multicenter Study of Glucose Tolerance in Cystic Fibrosis
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 82